BR0308584A - Composição farmacêutica androgênica e método para tratamento de depressão - Google Patents
Composição farmacêutica androgênica e método para tratamento de depressãoInfo
- Publication number
- BR0308584A BR0308584A BR0308584-8A BR0308584A BR0308584A BR 0308584 A BR0308584 A BR 0308584A BR 0308584 A BR0308584 A BR 0308584A BR 0308584 A BR0308584 A BR 0308584A
- Authority
- BR
- Brazil
- Prior art keywords
- androgenic
- pharmaceutical composition
- depressive disorder
- treating depression
- treating
- Prior art date
Links
- 230000001548 androgenic effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 229960003604 testosterone Drugs 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/098,232 US20040002482A1 (en) | 2000-08-30 | 2002-03-15 | Androgen pharmaceutical composition and method for treating depression |
| PCT/US2003/007910 WO2004091631A1 (en) | 2002-03-15 | 2003-03-14 | Androgen pharmaceutical composition and method for treating depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0308584A true BR0308584A (pt) | 2005-02-22 |
Family
ID=34192609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0308584-8A BR0308584A (pt) | 2002-03-15 | 2003-03-14 | Composição farmacêutica androgênica e método para tratamento de depressão |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20090318398A1 (uk) |
| AR (1) | AR036970A1 (uk) |
| BR (1) | BR0308584A (uk) |
| EA (1) | EA007431B1 (uk) |
| IL (3) | IL163981A0 (uk) |
| NO (1) | NO345056B1 (uk) |
| NZ (1) | NZ535368A (uk) |
| OA (1) | OA12856A (uk) |
| TW (1) | TWI339122B (uk) |
| UA (1) | UA80964C2 (uk) |
| ZA (1) | ZA200407403B (uk) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
| US8883769B2 (en) | 2003-06-18 | 2014-11-11 | White Mountain Pharma, Inc. | Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
| US20040259852A1 (en) | 2003-06-18 | 2004-12-23 | White Hillary D. | Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome |
| EP1530965B1 (en) | 2003-11-11 | 2006-03-08 | Mattern, Udo | Controlled release delivery system of sexual hormones for nasal application |
| FI3456329T3 (fi) | 2005-10-12 | 2025-02-27 | Besins Healthcare Lu Sarl | Parannettu testosteronigeeli ja käyttömenetelmä |
| US20100144687A1 (en) | 2008-12-05 | 2010-06-10 | Glaser Rebecca L | Pharmaceutical compositions containing testosterone and an aromatase inhibitor |
| JP6912852B2 (ja) | 2010-11-18 | 2021-08-04 | ホワイト マウンテン ファーマ，インコーポレイテッド | 対象における慢性または解決不能な疼痛を処置するための、および／または痛覚閾値を高めるための方法、およびこれに用いる医薬組成物 |
| AR086400A1 (es) | 2011-05-13 | 2013-12-11 | Trimel Pharmaceuticals Corp | Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo |
| US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
| US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
| EP3922235A1 (en) * | 2020-06-11 | 2021-12-15 | Viramal Limited | A hydroalcoholic gel and a method of manufacturing said gel |
| US12310974B1 (en) | 2023-12-19 | 2025-05-27 | Samuel Aballea | Method of treating post-traumatic stress disorder with carpipramine |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4861764A (en) * | 1986-11-17 | 1989-08-29 | Macro Chem. Corp. | Percutaneous absorption enhancers, compositions containing same and method of use |
| US5238944A (en) * | 1988-12-15 | 1993-08-24 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
| EP0462189B1 (en) * | 1989-03-10 | 1995-09-27 | Endorecherche Inc. | Combination therapy for treatment of estrogen sensitive diseases |
| US5788983A (en) * | 1989-04-03 | 1998-08-04 | Rutgers, The State University Of New Jersey | Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes |
| US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
| US5698589A (en) * | 1993-06-01 | 1997-12-16 | International Medical Innovations, Inc. | Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
| NZ293849A (en) * | 1994-09-14 | 1998-10-28 | Minnesota Mining & Mfg | Transdermal delivery matrix comprising a macromonomer containing acrylate or metacrylate copolymer, a softener and a drug |
| US5730987A (en) * | 1996-06-10 | 1998-03-24 | Omar; Lotfy Ismail | Medication for impotence containing lyophilized roe and a powdered extract of Ginkgo biloba |
| US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
| US6019997A (en) * | 1997-01-09 | 2000-02-01 | Minnesota Mining And Manufacturing | Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
| EP0998289A1 (en) * | 1997-02-07 | 2000-05-10 | TheraTech, Inc. | Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency |
| ES2318233T3 (es) * | 1997-11-10 | 2009-05-01 | Strakan International Limited | Sistemas mejoradores de la penetracion y reductores de la irritacion que comprenden testosterona. |
| US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
| US5880117A (en) * | 1998-07-13 | 1999-03-09 | Arnold; Patrick | Use of 4-androstenediol to increase testosterone levels in humans |
| US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
| US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| CN100349572C (zh) * | 2000-08-30 | 2007-11-21 | 尤尼麦德制药公司 | 提高妇女睾酮和相关类固醇浓度的方法 |
| US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
| US20030027804A1 (en) * | 2001-06-27 | 2003-02-06 | Van Der Hoop Roland Gerritsen | Therapeutic combinations for the treatment of hormone deficiencies |
| US20040072810A1 (en) * | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| FR2848112B1 (fr) * | 2002-12-10 | 2007-02-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations |
| FR2851470B1 (fr) * | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
| US20050020552A1 (en) * | 2003-07-16 | 2005-01-27 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
| FI3456329T3 (fi) * | 2005-10-12 | 2025-02-27 | Besins Healthcare Lu Sarl | Parannettu testosteronigeeli ja käyttömenetelmä |
| KR101426364B1 (ko) * | 2006-09-11 | 2014-08-05 | 세키스이가가쿠 고교가부시키가이샤 | 첩부제 |
-
2003
- 2003-03-14 BR BR0308584-8A patent/BR0308584A/pt not_active Application Discontinuation
- 2003-03-14 EA EA200401210A patent/EA007431B1/ru unknown
- 2003-03-14 TW TW092105579A patent/TWI339122B/zh not_active IP Right Cessation
- 2003-03-14 OA OA1200400248A patent/OA12856A/en unknown
- 2003-03-14 NZ NZ535368A patent/NZ535368A/en not_active IP Right Cessation
- 2003-03-14 UA UA20040907532A patent/UA80964C2/uk unknown
- 2003-03-14 AR ARP030100900A patent/AR036970A1/es not_active Application Discontinuation
- 2003-03-14 ZA ZA200407403A patent/ZA200407403B/en unknown
- 2003-03-14 IL IL16398103A patent/IL163981A0/xx unknown
-
2004
- 2004-09-09 IL IL163981A patent/IL163981A/en active IP Right Grant
- 2004-10-13 NO NO20044342A patent/NO345056B1/no not_active IP Right Cessation
-
2009
- 2009-08-19 US US12/543,541 patent/US20090318398A1/en not_active Abandoned
-
2011
- 2011-06-21 US US13/165,545 patent/US20110306582A1/en not_active Abandoned
- 2011-10-26 IL IL215944A patent/IL215944A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| TWI339122B (en) | 2011-03-21 |
| NZ535368A (en) | 2007-06-29 |
| IL163981A (en) | 2011-11-30 |
| IL215944A0 (en) | 2011-12-29 |
| NO20044342L (no) | 2004-12-06 |
| US20110306582A1 (en) | 2011-12-15 |
| EA200401210A1 (ru) | 2005-08-25 |
| US20090318398A1 (en) | 2009-12-24 |
| NO345056B1 (no) | 2020-09-07 |
| TW200412976A (en) | 2004-08-01 |
| UA80964C2 (en) | 2007-11-26 |
| ZA200407403B (en) | 2007-09-26 |
| IL163981A0 (en) | 2005-12-18 |
| IL215944A (en) | 2014-09-30 |
| OA12856A (en) | 2006-09-15 |
| HK1082677A1 (zh) | 2006-06-16 |
| AR036970A1 (es) | 2004-10-20 |
| EA007431B1 (ru) | 2006-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113649A (pt) | Processo para aumentar a testosterona e as relacionadas concentrações de esteróide em mulheres | |
| BR0316203A (pt) | Uso de um agente antialérgico e um esteróide para tratar rinite alérgica | |
| CY1110085T1 (el) | Μεθοδος θεραπειας της δυσλειτουργιας στυσης και αυξησης της λιμπιντο στους ανδρες | |
| BR0308584A (pt) | Composição farmacêutica androgênica e método para tratamento de depressão | |
| Zhou et al. | Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation | |
| BRPI0414435A (pt) | métodos e reagentes para o tratamento de distúrbios imunoinflamatórios | |
| BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
| BRPI0409348A (pt) | formulações e métodos para tratamento de rinossinusite | |
| BRPI0414277A (pt) | métodos e composições para o tratamento de dor e outras condições mediadas adrenérgicas alfa 2 | |
| ATE320803T1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
| BR0211062A (pt) | Combinações para o tratamento de distúrbios inflamatórios | |
| BRPI0407375A (pt) | Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos | |
| BRPI0410927A (pt) | métodos terapêuticos e profiláticos para distúrbios neuromusculares | |
| BR0013122A (pt) | Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina | |
| BRPI0502346A (pt) | processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica | |
| BR0206639A (pt) | Combinações de inibidor(es) da absorção do esterol com modificador(es) do sangue para o tratamento de condições vasculares | |
| DE60116256D1 (de) | Zusammensetzungen zur abgabe von cortisolantagonisten | |
| BR0314192A (pt) | Antagonistas de receptores de mglu para tratamento de distúrbios associados com receptores de mglu incluindo vìcio e depressão | |
| BRPI0412919A (pt) | combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos | |
| BR0313624A (pt) | Agonismo do receptor 5ht2a para tratamento da disfunção termo-regulatória | |
| ATE531366T1 (de) | Zusammensetzungen und verfahren zur behandlung, verminderung, verbesserung oder linderung von erkrankungen des hinteren augensegments | |
| BR9808606A (pt) | Materiais e métodos para tratamento de doenças com ribozimas | |
| BRPI0511367A (pt) | uso de uma composição,composição, uso de vip e/ou de um fragmento ativo do mesmo | |
| MX344197B (es) | Composiciones farmaceuticas para la terapia de reemplazo de glucocorticoides. | |
| BR0315314A (pt) | Método para o tratamento ou prevenção de sintomas de vasomotores em um paciente com necessidade do mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PARA:INT.CI. A61K 31/56, A61P 25/24 Ipc: A61K 31/56 (2011.01), A61P 25/24 (2011.01) |
|
| B25D | Requested change of name of applicant approved |
Owner name: LABORATOIRES BESINS INTERNATIONAL (FR) , UNIMED PH |
|
| B25A | Requested transfer of rights approved |
Owner name: UNIMED PHARMACEUTICALS, LLC (US) , BESINS HEALTHCA |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |